Small Molecules in Hematology

Häftad, Engelska, 2019

Del 212 i serien Recent Results in Cancer Research

930 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

It covers a wide range of small molecules including tyrosine kinase inhibitors, immunomodulatory drugs, the IDH-2 inhibitor enasidenib, the BCL-2 inhibitor venetoclax, and the proteasome inhibitor carfilzomib.

Produktinformation

Utgivningsdatum:2019-01-10
Mått:155 x 235 x 20 mm
Vikt:464 g
Format:Häftad
Språk:Engelska
Serie:Recent Results in Cancer Research
Antal sidor:294
Upplaga:3
Förlag:Springer Nature Switzerland AG
ISBN:9783030082567

Utforska kategorier

Onkologi inom Medicin
Hematologi inom Medicin

Mer om författaren

Uwe Martens, Prof. Dr. med., is chair of the Cancer Center Heilbronn-Franken and head of the Department of Hematology and Oncology at the SLK Clinic Heilbronn, which is an academic teaching hospital of the University of Heidelberg. He graduated in Medicine from the University of Freiburg and continued his medical and scientific training at the Medical University Center in Freiburg and at the BC Cancer Research Center in Vancouver. His scientific focus is the development of personalized cancer therapy and immunotherapy. He is a co-founder of the MOLIT Institute for Personalized Medicine at the science and technology park in Heilbronn, which aims to rapidly translate precision medicine into standard care.

Innehållsförteckning

Imatinib .- Dasatinib .- Nilotinib .- Bosutinib .- Ponatinib .- Ruxolitinib .- Ibrutinib .- Lenalidomide .- Pomalidomide .- Enasidenib .- Midostaurin .- Alectinib .- Osimertinib .- Venetoclax .- Idelaslisib .- Carfilzomib .- Acalabrutinib.